Brief: NeuroOne Announces Approval For Nasdaq Capital Market Listing
May 25 (Reuters) - Neuroone Medical Technologies Corp
NMTC.PK :
* NEUROONE ANNOUNCES APPROVAL FOR NASDAQ CAPITAL MARKET
LISTING;
TRADING EXPECTED TO COMMENCE TOMORROW MAY 26TH, 2021 UNDER THE
SYMBOL NMTC
Source text for Eikon: ID:nPnHwBwNa
Further company coverage: NMTC.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroone Medical Technologies
See all newsBrief: Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing
NeuroOne Medical Technologies Corp reports results for the quarter ended June 30 - Earnings Summary
NeuroOne Medical Technologies Corp expected to post a loss of 22 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings
NASDAQ RESUMED AT 09:00 AM